Given the pleiotropic role of HIF-1α in tumorigenesis and metastasis, as well as the increasing evidence that stem cells may evolve de novo from non-stem cells, targeting both the TIC and non-TIC ("bulk") populations in breast cancer is likely necessary to successfully treat primary breast cancer and to prevent metastasis. The gene discussed is HIF1A; the disease is breast carcinoma.